期刊文献+

IL-23促进人肺腺癌A549细胞的迁移和侵袭 被引量:3

Interleukin 23 Promotes Lung Adenocarcinoma A549 Cell Migration and Invasion
下载PDF
导出
摘要 背景与目的前炎症因子白细胞介素23(interleukin 23,IL-23)是与慢性炎症和肿瘤微环境相关的一种重要的细胞因子,同时IL-23受体在结直肠癌、肺癌、口腔鳞癌等肿瘤细胞中有表达。本研究旨在探讨IL-23能否促进人肺腺癌细胞A549的迁移和侵袭并探讨其机制。方法用划痕试验和Transwell小室法测定IL-23对A549的迁移和侵袭的影响,用Real-time PCR和ELISA检测IL-23对基质金属蛋白酶9(matrix metalloproteinase 9,MMP-9)的mRNA和蛋白表达的影响,通过IL-23中和抗体阻断IL-23的作用,进一步证实IL-23对A549迁移和侵袭的影响。结果 IL-23明显增加了A549细胞的迁移和侵袭能力;同时IL-23能提高A549细胞MMP-9的mRNA表达和其培养上清中MMP-9的蛋白表达,IL-23中和抗体能有效地阻断IL-23对A549的迁移和侵袭的作用。结论 IL-23可刺激A549细胞表达MMP-9,从而促进A549细胞的迁移和侵袭。 Background and objective Interleukin 23(IL-23) is a pro-inflammatory cytokine that plays an important role in inflammatory disease and tumor microenvironment.The IL-23 receptor is expressed in colon,lung,and oral carcinomas.We performed this study to investigate whether IL-23 promotes directly carcinoma cell migration and invasion as well as further explore its mechanism.Methods The migration and invasion of human lung adenocarcinoma A549 cells induced by IL-23 were detected by a scratch test and Transwell experiment.MMP-9 expression of the mRNA and protein levels of A549 cells cultured with and without IL-23 was respectively detected by Real-time PCR and ELISA.The effect of IL-23 on A549 cells was further verified using anti-IL-23p19 neutralization antibody(Ab IL-23p19) to eliminate IL-23.Results IL-23 remarkably promoted A549 cell migration and invasion.MMP-9 expression in A549 cells was upregulated by IL-23 stimulation.In addition,the effect of IL-23 on the migration and invasion of A549,as well as the MMP-9 expression in A549 cells induced by IL-23,was eliminated by Ab IL-23p19.Conclusion IL-23 promotes the migration and invasion of A549 cells by inducing MMP-9 expression.
出处 《中国肺癌杂志》 CAS 北大核心 2012年第5期253-259,共7页 Chinese Journal of Lung Cancer
关键词 IL-23 A549肺腺癌细胞 迁移 侵袭 MMP-9 IL-23 Lung adenocarcinoma cells A549 Migration Invasion MMP-9
  • 相关文献

参考文献25

  • 1Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357(9255): 539-545.
  • 2Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common andimportant factor in the pathogenesis of neoplasia. CA Cancer J Clin, 2006, 56(2): 69-83.
  • 3Matsuzaki K, Murata M, Yoshida K, el al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology, 2007, 46 ( 1 ): 48-57.
  • 4Philpott M, Ferguson LR. Immunonutrition and cancer. Mutat Res, 2004, 551(1-2): 29-42.
  • 5Langowski JL, Zhang X, Wu L, et al. IL-23 promotes tumour incidence and growth. Nature, 2006, 442(7101): 461-465.
  • 6McGeachy MJ, Cua DJ. Tn17 cell differentiation: the long and winding road. Immunity, 2008, 28 (4): 445-453.
  • 7Parham C, Chirica M, Timas J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R betal and a novel cytokine receptor subunit, IL-23R. J Immunol, 2002, 168 (11): 5699-5708.
  • 8Piskin G, Sylva-Steenland RM, Bos JD, et al. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol, 2006, 176 (3): 1908-1915.
  • 9Teng MW, yon Scheidt B, Duret H, et al. Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases. Cancer Res, 2011, 71 (6): 2077-2086.
  • 10Fukuda M, Ehara M, Suzuki S, et al. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. Int J Oncol, 2010, 36(6): 1355-1365.

同被引文献30

  • 1Kortylewski M, Xin H, Kujawski M, et al. Regulation of the IL - 23 and IL - 12 balance by Stat3 signaling in the tumor microenvironment [J] . Cancer Cell, 2009,3615): 114-123.
  • 2Chen Z, Ding J, Pang N et al. The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients [J]. Diagn Pathol, 2013,8(15) .sr.
  • 3Bogowski W, Deskur A, Budkowska M, et al. Selected cytokines in patients with pancreatic cancer: a preliminary report [J]. PLoS One, 2014,9(5) :e97613.
  • 4Khodadadi A, Razmkhah M, Eskandari AR, et al. IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer [J]. Iran J Med Sci, 2014,39(4) :350-356.
  • 5McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road[J]. Immunity, 2008, 28( 4) :445-453.
  • 6Baird AM, Leonard J, Naicker KM, et al. IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer[J]. Lung Cancer, 2013,79: 83- 90.
  • 7Wang L, Tangsheng YI, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway [J]. JEM, 2009,206(7): 1457-1464.
  • 8Qian X, Gu L, Ning H, et al. Increased Th17 cells in the tumor microenvironment is ediated by IL-23 via tumor-secreted prostaglandin E2[J]. Immunol, 2013,190: 5894-5902.
  • 9Li J, Lau G, Chen L, et al. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF - kappa B inducedmatrix metalloproteinase 9 expression [J]. PLoS One, 2012 , 7 (9) : e46264.
  • 10Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011,61(2) : 69 -90.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部